title: Investigation of the inhibitory effects of HA-1077 and Y-32885 on the translocation of PKCbetaI, PKCbetaII and PKCzeta in human neutrophils.
abstract: To transmit the information inside the cell, one possibility is the action of an enzyme called kinase that phosphorylates other proteins. To study these enzymes, chemical compound synthesis was needed to know the function and the mechanism of activation. The major difficulty is creating a specific molecule for one kinase. In this study, we test the action of Rho-kinase inhibitors (HA-1077 and Y-32885) on protein kinase C (PKC) in the respiratory burst in the human polymorphonuclear neutrophils. We have shown that these compounds could inhibit the anion superoxide production. To prove their action on PKC, we have shown a decrease of binding of a specific ligand (phorbol-12,13-dibutyrate) with each inhibitor. During its activation, PKC was translocated from the cytoplasm to the plasmic membrane. We have also shown an inhibition of this translocation, proving an inhibition of PKC by HA-1077 and Y-32885.
authors.affiliation: Faculté des Sciences Pharmaceutiques et Biologiques, Laboratoire de Pharmacologie, Pharmacocinétique et Pharmacie Cliniques, Lille, France. xavier.SIOMBOING@wanadoo.fr
authors.forename: X
authors.initials: X
authors.lastname: Siomboing
authors.forename: B
authors.initials: B
authors.lastname: Gressier
authors.forename: T
authors.initials: T
authors.lastname: Dine
authors.forename: C
authors.initials: C
authors.lastname: Brunet
authors.forename: M
authors.initials: M
authors.lastname: Luyckx
authors.forename: M
authors.initials: M
authors.lastname: Cazin
authors.forename: J C
authors.initials: JC
authors.lastname: Cazin
mesh_terms: D019307:1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine / Q000031:analogs & derivatives* / Q000494:pharmacology*; D000975:Antioxidants / Q000378:metabolism; D001549:Benzamides / Q000494:pharmacology*; D015153:Blotting, Western; D004789:Enzyme Activation / Q000187:drug effects; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D006801:Humans; D066298:In Vitro Techniques; D007527:Isoenzymes / Q000032:analysis / Q000037:antagonists & inhibitors / Q000378:metabolism*; D009504:Neutrophils / Q000187:drug effects* / Q000201:enzymology*; D010703:Phorbol Esters / Q000378:metabolism / Q000494:pharmacology; D011485:Protein Binding; D011493:Protein Kinase C / Q000032:analysis / Q000037:antagonists & inhibitors / Q000378:metabolism*; D064546:Protein Kinase C beta; D011725:Pyridines / Q000494:pharmacology*; D016897:Respiratory Burst / Q000187:drug effects; D013481:Superoxides / Q000378:metabolism; D000099221:Protein Kinase C zeta
chemical_list: D019307:1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; D000975:Antioxidants; D001549:Benzamides; D004791:Enzyme Inhibitors; D007527:Isoenzymes; D010703:Phorbol Esters; D011493:Protein Kinase C; D064546:Protein Kinase C beta; D011725:Pyridines; D013481:Superoxides; D000099221:Protein Kinase C zeta; C460080:Y 32885; C049347:fasudil